Publication Name	World Journal of Clinical Cases
Manuscript ID	76989
Country	China

Received	2022-04-13 08:31
Peer-Review Started	2022-04-09 16:14
To Make the First Decision
Return for Revision	2022-06-16 01:33
Revised	2022-06-24 14:24
Second Decision	2022-08-22 03:09
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-08-25 20:51
Articles in Press	2022-08-25 20:51
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-08-16 13:36
Typeset the Manuscript	2022-09-07 04:06
Publish the Manuscript Online	2022-09-27 13:00

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Case Report
Article Title	Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Lin-Jie Li and Jun-Yu Zhang
Funding Agency and Grant Number	Funding Agency Grant Number Medical Health Science and Technology Project of Zhejiang Province Health Commission No. 2020376298
Corresponding Author	Lin-Jie Li, Doctor, Chief Doctor, Department of Hematology, Lishui Municipal Central Hospital, No. 289 KuoCang Load, Lishui 323000, Zhejiang Province, China. lilinjie0394@163.com
Key Words	NK-T cell lymphoma; Refractory/relapsed; Anti-PD-1; Decitabine; Case report
Core Tip	Extranodal natural killer/T cell lymphoma nasal type (ENKL) is a highly aggressive malignancy characterized by its association with Epstein-Barr virus (EBV) and extranodal involvement, which shows a poor clinical outcome. Now, we report a rare case of relapsed/refractory classic Hodgkin lymphoma with resistance to anti-PD-1 in which anti-PD-1 combined with decitabine showed positive preliminary results. Our findings support the potential benefit of anti-PD-1 combined with decitabine in this type of refractory T-cell lymphoma.
Publish Date	2022-09-27 13:00
Citation	Li LJ, Zhang JY. Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report. World J Clin Cases 2022; 10(28): 10193-10200
URL	https://www.wjgnet.com/2307-8960/full/v10/i28/10193.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i28.10193

Full Article (PDF)	WJCC-10-10193.pdf
Full Article (Word)	WJCC-10-10193.docx
CARE Checklist–2016	76989-CARE-Checklist–2016-revision.docx
Manuscript File	76989_Auto_Edited-YLC-Wang TQ-LS.docx
Answering Reviewers	76989-Answering reviewers.pdf
Audio Core Tip	76989-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	76989-Conflict-of-interest statement.pdf
Copyright License Agreement	76989-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	76989-Grant application form(s).pdf
Signed Consent for Treatment Form(s) or Document(s)	76989-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	76989-Language certificate.pdf
Peer-review Report	76989-Peer-review(s).pdf
Scientific Misconduct Check	76989-Bing-Chen YL-2.png
Scientific Editor Work List	76989-Scientific editor work list.pdf
CrossCheck Report	76989-CrossCheck report.pdf